GlassScriptPhysician profile
Polydoros Kampaktsis
NPI 1316387483
$88,363.03
in general payments reported to CMS, 2019-2025
13 companies · $14K in 2025
The $14K reported for 2025 was more than what 95% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $158 · 2022: $23.01 · 2023: $319 · 2024: $74K · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $82K · Food and Beverage: $3,562 · Travel and Lodging: $2,807.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $81,811.80 |
| Food and Beverage | $3,562.46 |
| Travel and Lodging | $2,807.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $47,557.69 | 2024-2025 | Mitraclip, Cardiomems, Amplatzer Amulet |
| Medtronic, INC. | $37,880.95 | 2024-2025 | Corevalve Evolut R |
| Edwards Lifesciences Corporation | $1,954.46 | 2024-2025 | Evoque, Pascal, Inspiris Resilia Aortic Valve |
| Boston Scientific Corporation | $234.28 | 2023-2025 | Rotapro, Watchdog, Watchman |
| Abiomed | $183.71 | 2024-2025 | Impella |
| Janssen Pharmaceuticals, INC | $150.00 | 2023 | Xarelto |
| W. L. Gore & Associates, INC. | $106.91 | 2024-2025 | Gore Cardioform Septal Occluder, Gore Septal Occluder |
| Terumo Medical Corporation | $79.20 | 2021 | |
| Angiodynamics, INC. | $79.20 | 2021 | |
| Cardiva Medical, INC. | $71.09 | 2024-2025 | Savvywire |
| Cardiac Dimensions, INC. | $23.04 | 2024 | |
| Novartis Pharmaceuticals Corporation | $23.01 | 2022 | |
| Pfizer INC. | $19.49 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Polydoros Kampaktsis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.